{
  "id": 6594,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Co-hosts",
      "inferred_vibe": "Informative and concerned"
    },
    "dialogue_turns": [
      {
        "speaker": "HostA",
        "text": "People think antibiotics are all the same, but actually the WHO has a whole classification tool to guide their use.",
        "tts_text": "People think antibiotics are all the same, but actually the W H O has a whole classification tool to guide their use.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The AWaRe tool was developed by the WHO Essential Medicines List to contain rising resistance and make antibiotic use safer and more effective.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Right, the AWaRe tool—it splits them into three groups: Access, Watch, and Reserve. It's meant to make prescribing way more targeted.",
        "tts_text": "Right, the AWaRe tool-it splits them into three groups: Access, Watch, and Reserve. It's meant to make prescribing way more targeted.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "It classifies antibiotics into three groups Access, Watch and Reserve and specifies which antibiotics to use for the most common and serious infections, which ones should be available at all times in the healthcare system, and those that must be used sparingly or preserved and used only as a last resort.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Exactly, and the goal is to get at least 60% of global antibiotic use into that Access category, which are these narrow-spectrum, cheaper options.",
        "tts_text": "Exactly, and the goal is to get at least sixty percent of global antibiotic use into that Access category, which are these narrow-spectrum, cheaper options.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "The new campaign aims to increase the proportion of global consumption of antibiotics in the Access group to at least 60%, and to reduce use of the antibiotics most at risk of resistance from the Watch and Reserve groups. Using Access antibiotics lowers the risk of resistance because they are narrow-spectrum antibiotics (that target a specific microorganism rather than several).",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Which is huge because, uh, over 50% of antibiotics are used inappropriately in many countries right now. That's driving resistance.",
        "tts_text": "Which is huge because, uh, over fifty percent of antibiotics are used inappropriately in many countries right now. That's driving resistance.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Currently, it is estimated that more than 50% of antibiotics in many countries are used inappropriately such as for treatment of viruses when they only treat bacterial infections or use of the wrong (broader spectrum) antibiotic, thus contributing to the spread of antimicrobial resistance.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "Dr. Tedros called antimicrobial resistance one of the most urgent health risks—it could undo a century of medical progress.",
        "tts_text": "Dr. Tedros called antimicrobial resistance one of the most urgent health risks-it could undo a century of medical progress.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Antimicrobial resistance is one of the most urgent health risks of our time and threatens to undo a century of medical progress, said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "And it's not just about overuse; some places still lack access to basic antibiotics. Childhood pneumonia deaths are close to a million a year because of that gap.",
        "tts_text": "And it's not just about overuse; some places still lack access to basic antibiotics. Childhood pneumonia deaths are close to a million a year because of that gap.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Childhood deaths due to pneumonia (estimated globally at close to one million per year) because of lack of access to antibiotics remain frequent in many parts of the world.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "So the tool tries to balance both—ensuring availability while preserving last-resort drugs like those in the Reserve group.",
        "tts_text": "So the tool tries to balance both-ensuring availability while preserving last-resort drugs like those in the Reserve group.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Tackling antimicrobial resistance requires a careful balance between access and preservation, said Dr Hanan Balkhy, WHO Assistant-Director General for antimicrobial resistance. The AWaRe tool can guide policy to ensure patients keep being treated, while also limiting use of the antibiotics most at risk of resistance.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Yeah, 'cause once those stop working, we're talking about infections that are just… untreatable. Dr. Simão called it an \"invisible pandemic.\"",
        "tts_text": "Yeah, 'cause once those stop working, we're talking about infections that are just... untreatable. Dr. Simão called it an invisible pandemic.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Antimicrobial resistance is an invisible pandemic, said Dr Maringela Simão, Assistant-Director General for Access to Medicines. We are already starting to see signs of a post-antibiotic era, with the emergence of infections that are untreatable by all classes of antibiotics.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "And it's not just a medical issue—it hits health budgets hard too. Resistant infections mean longer hospital stays, costlier treatments.",
        "tts_text": "And it's not just a medical issue-it hits health budgets hard too. Resistant infections mean longer hospital stays, costlier treatments.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "When antibiotics stop working effectively, more expensive treatments and hospital admissions are needed, taking a heavy toll on already stretched health budgets.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "Even though more than a hundred countries have plans against antimicrobial resistance, only like a fifth are actually funded and implemented.",
        "tts_text": "Even though more than a hundred countries have plans against antimicrobial resistance, only like a fifth are actually funded and implemented.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "And although over 100 countries have put in place national plans to tackle antimicrobial resistance, only about one fifth of those plans are funded and implemented.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostA",
        "text": "So tools like AWaRe give clear guidance—helping health workers choose the right antibiotic at the right time without overcomplicating things.",
        "tts_text": "So tools like AWaRe give clear guidance-helping health workers choose the right antibiotic at the right time without overcomplicating things.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "By classifying antibiotics into three distinct groups, and advising on when to use them, AWaRe makes it easier for policy-makers, prescribers and health workers to select the right antibiotic at the right time, and to protect endangered antibiotics.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "HostB",
        "text": "It's practical, it's structured—and honestly, with so few new antibiotics in development, we really need to use what we have smarter.",
        "tts_text": "It's practical, it's structured-and honestly, with so few new antibiotics in development, we really need to use what we have smarter.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "In the absence of new significant investments into the development of new antibiotics, improving the use of antibiotics is one of the key actions needed to curb further emergence and spread of antimicrobial resistance.",
        "confidence": 1.0,
        "priority": "high"
      }
    ]
  },
  "generator_model": "DeepSeek-V3.1",
  "batch_index": 2
}